CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunityRamin Salehi‐Rad, Steven M. Dubinett, Jensen Abascal et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 30
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi‐Rad, Steven M. Dubinett, Raymond J. Lim et al.|Cancer Immunology Immunotherapy|2021Cited by 24